During the past decade, Nzoz Novo Med conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 2 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Nzoz Novo Med" are "Alzheimer Disease" (1 trials), "Epilepsy, Partial Seizures" (1 trials), "Epilepsy, Primary Generalized Tonic-Clonic Seizures" (1 trials), "Generalized Tonic Clonic Seizures" (1 trials) and "Multiple Sclerosis" (1 trials). Many other conditions were trialed in "Nzoz Novo Med" in a lesser frequency.

Most popular intervention types in "Nzoz Novo Med" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "GV-971" (1 trials), "Pregabalin" (1 trials), "Pregabalin Dose Level 1" (1 trials) and "Pregabalin Dose Level 2" (1 trials). Other intervention names were less common.

The vast majority of trials in "Nzoz Novo Med" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Nzoz Novo Med". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Nzoz Novo Med, 1 suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Nzoz Novo Med, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".